Navigation Links
Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
Date:10/23/2008

Details to be presented at NACFC and ICAAC/IDSA meetings this week

SAN DIEGO, Oct. 23 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that aerosol dosing of MP-376 was well tolerated at all dose levels tested after 14 days of dosing. Encouraging signs of drug activity were also observed in this trial. New preclinical results demonstrate that MP-376 has potent activity against Pseudomonas aeruginosa (P. aeruginosa) infection under a wide array of conditions, avoids resistance development when used at high concentrations achievable with aerosol dosing and has anti-inflammatory properties in pulmonary tissues in addition and unrelated to its antibacterial effects. Detailed results are being presented at the North American Cystic Fibrosis Conference (NACFC) and ICAAC/IDSA meetings taking place this week in Orlando, Florida and Washington, D.C., respectively.

Clinical Results

The clinical results being presented at NACFC are from a Phase 1b safety, tolerability and pharmacokinetic (PK) study performed in 40 CF patients with stable disease at 11 U.S. clinical sites (Mpex 203). The study was a placebo-controlled, dose escalation trial to analyze the effects of 14 days of dosing at three different dose levels of MP-376 when administered by inhalation using an Investigational eFlow Nebulizer System.

All patients were required to be culture positive for P. aeruginosa at baseline. P. aeruginosa is a bacterial pathogen that is a leading cause of morbidity in CF patients. The great majority of CF patients over the age of 18 are chronically infected with this pathogen and chronic infection has been shown to lead to acute exacerbations and subsequent loss of l
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
2. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
3. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
4. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Critical Pharmaceuticals Enter Sustained Release hGH Arena
11. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Research ... "Biopharmaceutical and Vaccine Production Markets" report to ... many new therapies and vaccines - including products to ... are still huge challenges during the final stages of ... when and how to risk production capital to upscale ...
(Date:9/23/2014)... 2014 Rising health concerns, ... increasing number of foreign and domestic players in the ... India   The India ... high growth potential markets worldwide due to multiple factors ... the youth, changing food consumption patterns, increasing diabetic population, ...
(Date:9/23/2014)... SAN FRANCISCO , Sept. 23, 2014  SiteOne ... round of equity financing. Led by Sears Capital Management ... and Joe Zakrzewski , the $1.5 million financing ... inhibitor program for pain and to further develop its ... other pain indications. In conjunction with the ...
Breaking Medicine Technology:Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... Inc., (OTC Bulletin Board: NWCI ) a ... the second quarter ended June 30, 2010. More details ... 10-Q, filed with the Securities and Exchange Commission. ... made tremendous progress in commercializing our initial solution, QTinno™," ...
... Colo., Aug. 13 Mesa Laboratories, Inc. (Nasdaq: ... Directors has declared a regular quarterly cash dividend of ... September 15, 2010 to shareholders of record at the ... Mesa Laboratories develops, acquires, manufactures and markets electronic instruments ...
Cached Medicine Technology:NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 2NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 3NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 4NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 5NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 6NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 7NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 8NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 9NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress 10
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... who are already obese as teenagers could grow up ... peers of normal weight. So says Petter Lundborg of ... Rooth of Linneas University and Lund University, all in ... United Kingdom and the United States, and the results ... , The researchers analyzed large-scale data of 145,193 Swedish-born ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has recently announced ... in Vancouver, BC. The company will provide services on ... maintenance project or a large-scale new installation project, Pro ... needs of the individual commercial client. Pro Ace has ... affordable price. As a result, businesses of all sizes ...
(Date:9/23/2014)... 2014 The Sloane Clinic™, a ... and Malaysia providing advanced aesthetic dermatology and cosmetic ... its impressive skin care repertoire. Specially formulated with ... against the evil forces of aging, acne and ... this new addition is revolutionizing the way we ...
(Date:9/23/2014)... New York (PRWEB) September 23, 2014 ... in courts around the country, Bernstein Liebhard LLP reports. ... Middle District of Florida on September 19th, the Court ... a case filed in that jurisdiction on behalf of ... and other complications due to his use of Risperdal. ...
Breaking Medicine News(10 mins):Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... are helmets,enough for motorcyclists to protect themselves., ... Randall Dale,Chipkar considers motorcycle radiation a possible "Black ... higher risk for cancer development from,electromagnetic radiation shooting ... a paradox that thousands of motorcycle riders participate,in ...
... DIEGO, Dec. 3 The C-section has hit number ... Department of Health and Human,Services. Scarring, swelling, tenderness and ... annually., C-Panty, The After Cesarean Underwear(TM) attempts to ... underwear designed with the,post-surgical concerns of a C-section in ...
... HRAL),HearAtLast Holdings, Inc. announced today that their Official ... Oswald will be,featured on three news stations in ... and features are taking place in conjunction with,the ... will be co-located in,Wal-Mart Store #3065 located at ...
... in early 2008, TARRYTOWN, N.Y., Dec. 3 ... today announced that it has,completed patient enrollment in ... EpiCept NP-1 is a patented topical cream,formulation of ... ketamine,and is intended to provide long-term relief from ...
... COVER: Inside Putin,s Circle. (Atlantic and Latin America ... Anna Nemtsova,report that Russia,s real politics happens in ... for money and influence. As Vladimir Putin prepares,to ... the clans that,control the power of the Russian ...
... doctors and respect for role of parents are key, ... The death of a child is devastating for all ... doctor. , Complicating matters, even though more than 55,000 ... care -- which focuses on the pain, symptoms and ...
Cached Medicine News:Health News:Motorcycle Radiation May Be Linked to Cancer Risk 2Health News:Finally, Easy After-Cesarean Care for the 1.3 Million C-Section Moms 2Health News:HearAtLast Spokesperson Walter Gretzky and President Robert Oswald to be Featured on Three TV Segments in Conjunction with Ottawa Store Opening 2Health News:HearAtLast Spokesperson Walter Gretzky and President Robert Oswald to be Featured on Three TV Segments in Conjunction with Ottawa Store Opening 3Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 2Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 3Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 4Health News:NEWSWEEK: International Editions: Highlights and Exclusives, December 10, 2007 Issue 2Health News:NEWSWEEK: International Editions: Highlights and Exclusives, December 10, 2007 Issue 3Health News:NEWSWEEK: International Editions: Highlights and Exclusives, December 10, 2007 Issue 4Health News:NEWSWEEK: International Editions: Highlights and Exclusives, December 10, 2007 Issue 5Health News:Breaking Down Barriers to End-of-Life Care for Children 2Health News:Breaking Down Barriers to End-of-Life Care for Children 3
... The HDR disposable template is ... contamination and eliminate the need ... made with premium silicone molded ... ensures accurate needle placement while ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
... The latest introduction in the family of ... design of the stepping platform features a ... scale. The EXII steeping unit has a ... visual display of transducer position and a ...
Medicine Products: